TwinBeech Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

TwinBeech Capital’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,546	Closed	-$1.99M	–	928
2023 Q1	$1.99M	Buy	+18,546	New	+$2.13M	0.04%	377

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

TwinBeech Capital's RXDX Position: Q2 2023 in Review

TwinBeech Capital sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 18,546 shares — an estimated $1.99M sold.

TwinBeech Capital first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $1.99M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

TwinBeech Capital reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TwinBeech Capital sold 18,546 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $1.99M.
TwinBeech Capital first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
TwinBeech Capital's Prometheus Biosciences, Inc. Common Stock position peaked at $1.99M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on TwinBeech Capital's 13F filing for Q2 2023, filed 14 Aug 2023.